Display Settings:

Format

Send to:

Choose Destination

    Hepatology. 1989 Feb;9(2):215-8.

    Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

    Ludwig J, Kim CH, Wiesner RH, Krom RA.

    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905.

    A 43-year-old man underwent abdominoperineal resection of a rectal adenocarcinoma, and left hepatic lobectomy for a single metastasis. He then received hepatic artery infusions of floxuridine. The tumor did not recur, but sclerosing cholangitis and liver failure developed which necessitated orthotopic liver transplantation. In the hilus of the native liver, obstructive arteriopathy and portal venopathy were found. These lesions probably had been caused by drug-induced intravascular thrombosis. Thus, the sclerosing cholangitis that develops in many patients after floxuridine infusion may be ischemic rather than toxic. The patient described here is well, 14 months after orthotopic liver transplantation. Therefore, in some cases of floxuridine-induced cholangitis, liver transplantation appears to be indicated despite a history of metastasizing carcinoma.

    PMID: 2521475 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Floxuridine (FUDR®)

      Your doctor has ordered the drug floxuridine to help treat your illness. The drug is given by injection into a catheter that is placed in an artery.